-
Suh Receives Subaward from ICER
Pitt Pharmacy Assistant Professor Dr. Kangho Suh received a subaward to develop cost-effectiveness models for the Institute of Clinical and Economic Review (ICER) in collaboration with Dr. Josh Carlson from University of Washington, as part of ICER's drug assessment program. Drs. Suh and Carlson will develop two cost-effectiveness models for ICER. ICER’s reports include a full analysis of a drug’s comparative effectiveness, cost-effectiveness, and potential budget impact. ICER uses transparent methods to calculate for each new drug a value-based price benchmark anchored to the real benefits the drug brings to patients.
-
Radomski Receives Excellence in Patient Experience Award
CP3 Faculty Affiliate Dr. Tom Radomski was one of the 2020 recipients of the UPMC Excellence in Patient Experience Award. One patient described him as "attentive and personable." Congrats, Tom!
Learn more about Dr. Radomski's work here -
Essien Receives AAMC Award
CP3 Faculty Affiliate Dr. Utibe Essien received the Association of American Medical Colleges’ 2021 Herbert W. Nickens Faculty Fellowship Award. The award recognizes a junior faculty member committed to a career in academic medicine and displaying leadership in addressing disparities.
Learn more about Dr. Essien's work here -
Hernandez Receives Hersh Emerging Leader Award
Former CP3 Associate Director Dr. Inma Hernandez received the Alice S. Hersh Emerging Leader Award at the Academy Health 2021 Annual Research Meeting, for her past and potential contributions to health services research. Dr. Hernandez was nominated by her mentor, CP3 Director Dr. Walid Gellad.
Read more about the award
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
